Atlas Trials

CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT03473457 · TERMINATED

Trial details

NCT number
NCT03473457
Sponsor
Zhujiang Hospital
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Start date
2018-04-01
Primary completion
2020-12-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.